$3.51T
Total marketcap
$108.89B
Total volume
BTC 60.79%     ETH 9.05%
Dominance

Illumina ILMN Stock

84.43 USD {{ price }} 2.351803% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
13.37B USD
LOW - HIGH [24H]
82.1 - 85.06 USD
VOLUME [24H]
2.35M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-6.08 USD

Illumina Price Chart

Illumina ILMN Financial and Trading Overview

Illumina stock price 84.43 USD
Previous Close 204.84 USD
Open 203.96 USD
Bid 0 USD x 800
Ask 0 USD x 1000
Day's Range 203.17 - 211.24 USD
52 Week Range 173.45 - 248.87 USD
Volume 1.78M USD
Avg. Volume 1.24M USD
Market Cap 33.19B USD
Beta (5Y Monthly) 1.170422
PE Ratio (TTM) N/A
EPS (TTM) -6.08 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 238.25 USD

ILMN Valuation Measures

Enterprise Value 33.93B USD
Trailing P/E N/A
Forward P/E 66.017296
PEG Ratio (5 yr expected) -6.43
Price/Sales (ttm) 7.461943
Price/Book (mrq) 4.9558554
Enterprise Value/Revenue 7.628
Enterprise Value/EBITDA 87.222

Trading Information

Illumina Stock Price History

Beta (5Y Monthly) 1.170422
52-Week Change 12.09%
S&P500 52-Week Change 20.43%
52 Week High 248.87 USD
52 Week Low 173.45 USD
50-Day Moving Average 209.92 USD
200-Day Moving Average 209.96 USD

ILMN Share Statistics

Avg. Volume (3 month) 1.24M USD
Avg. Daily Volume (10-Days) 1.46M USD
Shares Outstanding 158.1M
Float 157.75M
Short Ratio 3.63
% Held by Insiders 0.28%
% Held by Institutions 93.54%
Shares Short 4.99M
Short % of Float 3.54%
Short % of Shares Outstanding 3.16%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 2:1

Financial Highlights

Fiscal Year

Fiscal Year Ends January 1, 2023
Most Recent Quarter (mrq) April 2, 2023
Next Fiscal Year End January 1, 2024

Profitability

Profit Margin -100.87%
Operating Margin (ttm) -0.47%
Gross Margin 67.28%
EBITDA Margin 8.74%

Management Effectiveness

Return on Assets (ttm) -0.097%
Return on Equity (ttm) -51.022%

Income Statement

Revenue (ttm) 4.45B USD
Revenue Per Share (ttm) 28.29 USD
Quarterly Revenue Growth (yoy) -11.099%
Gross Profit (ttm) 3.15B USD
EBITDA 389M USD
Net Income Avi to Common (ttm) -4487000064 USD
Diluted EPS (ttm) -28.25
Quarterly Earnings Growth (yoy) -96.50%

Balance Sheet

Total Cash (mrq) 1.52B USD
Total Cash Per Share (mrq) 9.6 USD
Total Debt (mrq) 3.06B USD
Total Debt/Equity (mrq) 45.75 USD
Current Ratio (mrq) 1.422
Book Value Per Share (mrq) 42.361

Cash Flow Statement

Operating Cash Flow (ttm) 230M USD
Levered Free Cash Flow (ttm) 448.88M USD

Profile of Illumina

Country United States
State CA
City San Diego
Address 5200 Illumina Way
ZIP 92122
Phone 858 202 4500
Website https://www.illumina.com
Industry Diagnostics & Research
Sector(s) Healthcare
Full Time Employees 11500

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; and whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Further, it provides whole-genome sequencing, genotyping, NIPT, and product support services; and Galleri, a multi-cancer early detection test. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Further, it markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

Q&A For Illumina Stock

What is a current ILMN stock price?

Illumina ILMN stock price today per share is 84.43 USD.

How to purchase Illumina stock?

You can buy ILMN shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Illumina?

The stock symbol or ticker of Illumina is ILMN.

Which industry does the Illumina company belong to?

The Illumina industry is Diagnostics & Research.

How many shares does Illumina have in circulation?

The max supply of Illumina shares is 158.3M.

What is Illumina Price to Earnings Ratio (PE Ratio)?

Illumina PE Ratio is now.

What was Illumina earnings per share over the trailing 12 months (TTM)?

Illumina EPS is -6.08 USD over the trailing 12 months.

Which sector does the Illumina company belong to?

The Illumina sector is Healthcare.

Illumina ILMN included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 19100.94 USD
-0.51
7.27B USD 19084.38 USD 19276.83 USD 7.27B USD
S&P 500 (Yahoo.com) GSPC 5888.55 USD
-0.56
2.55B USD 5881.88 USD 5939.92 USD 2.55B USD
S&P 500 INDEX SPX 5891.4 USD
-0.51
1.91B USD 5889.89 USD 5939.92 USD 1.91B USD
US100 NDX 21318.17 USD
-0.45
1.07B USD 21296.51 USD 21508.08 USD 1.07B USD
Dow Jones U.S. Biotechnology In DJUSBT 2489.61 USD
-0.72
96.22M USD 2482.71 USD 2516.71 USD 96.22M USD
Nasdaq CRD Global Sustainabilit NQCRD 1735.62 USD
0
1715.94 USD 1757.95 USD
NASDAQ-100 Ex-Tech Sector NDXX 5843.23 USD
-0.42
5836.04 USD 5881.79 USD
NASDAQ-100 Total Return XNDX 25823.41 USD
-0.45
25797.18 USD 26053.46 USD
Nasdaq-100 ESG JPY Index NDXESG07 2053.8 JPY 13.86 USD
-0.14
2051.92 JPY 13.85 USD 2073.53 JPY 14 USD
NASDAQ Biotechnology Total Retu XNBI 4429.24 USD
-0.88
4424.12 USD 4478.71 USD
Stlmt ID NASDAQ 100 XQO 16266.86 USD
-0.45
15738.2 USD 16639.8 USD
Nasdaq-100 Notional Net Return XNDXNNREUR 3925.31 EUR 4290.89 USD
-0.1
3924.67 EUR 4290.19 USD 3960.43 EUR 4329.29 USD
NASDAQ Biotechnology NBI 4086.22 USD
-0.88
4081.49 USD 4131.86 USD
NASDAQ-100 After Hours Indicato QIV 21339.25 USD
-0.35
21303.96 USD 21341.22 USD
Nasdaq Health Care IXHC 941.34 USD
-0.51
940.07 USD 947.81 USD
NASDAQ-100 Reduced Value Index NQX 4263.63 USD
-0.45
4259.3 USD 4301.62 USD
NASDAQ Global Select Market Com NQGS 9347.78 USD
-0.51
9339.71 USD 9434.23 USD
NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD 2100.38 AUD 1390.15 USD
<0.01
2100.38 AUD 1390.15 USD 2100.38 AUD 1390.15 USD
NASDAQ-100 Equal Weighted Total NETR 9467.9 USD
-0.67
9458.9 USD 9558.73 USD
Nasdaq-100 ESG Net Notional Tot NDXESG24 1675.5 EUR 1831.55 USD
-0.13
1675.33 EUR 1831.36 USD 1690.89 EUR 1848.37 USD